MedPath

A Study to Evaluate the Effects of Manidipine Versus Amlodipine and the Combination of Manidipine Plus Delapril Versus Amlodipine Plus Delapril on Intraglomerular Pressure in Hypertensive Patients

Registration Number
NCT00627952
Lead Sponsor
University of Erlangen-Nürnberg Medical School
Brief Summary

Eight-week multi-national, multicenter, randomized, double blind, active control, two arms, parallel groups study with a 4-week single drug treatment (manidipine or amlodipine) phase followed by a 4-week combination treatment (manidipine + delapril or amlodipine + delapril) phase.

Detailed Description

The aim of the current study is to assess the effect of a 4-week single drug treatment with manidipine or amlodipine and a 4-week combination treatment with manidipine plus delapril or amlodipine plus delapril on intraglomerular pressure in subjects with hypertension.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • male or female patients aged 18 years or older
  • mild to moderate hypertension (systolic blood pressure > 139 mmHg or diastolic blood pressure > 89 mmHg)
Exclusion Criteria
  • secondary form of arterial hypertension
  • severe hypertension (systolic blood pressure > 179 mmHg or diastolic blood pressure > 109 mmHg)
  • pregnant or lactating women

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
amlodipine 10 mgamlodipine 5 mg + delapril 30 mg-
manidipine 20 mgmanidipine 20 mg-
manidipine 20 mgmanidipine 10 mg + delapril 30 mg-
amlodipine 10 mgamlodipine 10 mg-
Primary Outcome Measures
NameTimeMethod
effect of manidipine 20 mg once daily compared to amlodipine 10 mg once daily on intraglomerular pressure4 weeks
Secondary Outcome Measures
NameTimeMethod
effects of combination of manidipine 10 mg plus delapril 30 mg once daily compared with once daily amlodipine 5 mg plus delapril 30 mg on intraglomerular pressure4 weeks

Trial Locations

Locations (1)

Clinical Research Center, Department of Nephrology and Hypertension, University of Erlangen-Nurnberg

🇩🇪

Erlangen, Bavaria, Germany

© Copyright 2025. All Rights Reserved by MedPath